Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies
Theranostics · 2026
DOI: 10.7150/thno.120357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Anu Rani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Arts and Sciences, Washington State University, 1470 NE College Ave, Pullman, WA, 99164, USA. Hauptthemen laut MEDLINE: Trehalose, Dendrimers, Axitinib, Drug Carriers. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Arts and Sciences, Washington State University, 1470 NE College Ave, Pullman, WA, 99164, USA.
- Integrative Biosciences Center, Wayne State University, Detroit, MI, 48202, USA.
- Department of Ophthalmology, Visual and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI, 48202, USA.
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Rani, A., Bisen, S., Sharma, R., Dar, A. I., Sharma, A., Dhull, A., Palmer, N., Goody, K. J., Singh, N. K., & Sharma, A. (2026). Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies. Theranostics. https://doi.org/10.7150/thno.120357
Vancouver
Rani A, Bisen S, Sharma R, Dar AI, Sharma A, Dhull A, et al. Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies. Theranostics. 2026. doi:10.7150/thno.120357
BibTeX
@article{Rani2026,
author = {Rani, Anu and Bisen, Shivantika and Sharma, Rishi and Dar, Aqib Iqbal and Sharma, Anamika and Dhull, Anubhav and Palmer, Nina and Goody, Kenneth John and Singh, Nikhlesh K and Sharma, Anjali},
title = {Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.120357}
}
EUVIMED